This inventor holds 1 USPTO granted patent. Top assignees: Albert Einstein College of Medicine, University of Pittsburgh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 514 
1 out of 1,963 
Years Active: 2025
Title: Thomas Leyh: Innovator in Sulfotransferase Inhibition
Introduction
Thomas Leyh is a notable inventor based in the Bronx, NY. He has made significant contributions to the field of biochemistry, particularly in the area of sulfotransferase inhibition. His work has implications for various therapeutic applications.
Latest Patents
Thomas Leyh holds a patent for "Small molecule inhibition of sulfotransferase SULT1A3." This patent provides small molecule compounds and methods for inhibiting human sulfotransferase 1A3 (SULT1A3). The patent also discloses methods of manufacturing and treatment using these compounds. He has 1 patent to his name.
Career Highlights
Throughout his career, Thomas Leyh has worked with prestigious institutions such as the University of Pittsburgh and Albert Einstein College of Medicine. His research has contributed to advancements in understanding sulfotransferase enzymes and their role in human health.
Collaborations
Some of his notable coworkers include Kristie E. Darrah and Ting Wang. Their collaborative efforts have furthered research in the field of biochemistry and drug development.
Conclusion
Thomas Leyh's innovative work in sulfotransferase inhibition showcases his dedication to advancing medical science. His contributions are valuable to the ongoing research in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile